Related Experiment Videos
Kidney function in lithium-treated patients. A literature survey.
Acta Psychiatrica Scandinavica
|November 1, 1983
Summary
Long-term lithium treatment can cause kidney damage, specifically tubulointerstitial changes and reduced tubular function. However, combined neuroleptic treatment does not increase kidney risk.
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Lithium is a mood stabilizer used in treating bipolar disorder.
- Long-term lithium use can affect renal function.
- The impact of lithium on kidney health requires ongoing investigation.
Purpose of the Study:
- To review existing studies on lithium's effects on kidney function.
- To assess risks associated with combined lithium and neuroleptic therapy.
- To determine if lithium preparations or dosing schedules influence kidney outcomes.
Main Methods:
- Systematic review of 23 studies involving approximately 1,450 patients.
- Analysis of kidney biopsy data from 132 patients.
- Evaluation of specific research questions regarding combination therapy and lithium formulations.
Main Results:
- Long-term lithium treatment is linked to tubulointerstitial changes and impaired tubular function in a subset of patients.
- Glomerular function reduction is secondary to tubular damage.
- Combined lithium and neuroleptic treatment did not elevate kidney damage risk.
Conclusions:
- Lithium can cause irreversible kidney function reduction in some individuals.
- Different lithium preparations do not appear to impact kidney differently.
- Multiple-dose lithium schedules may increase urinary output compared to single-dose schedules.
- Potential for increased renal dysfunction in lithium-treated patients necessitates monitoring.